Trade iShares Nasdaq Biotechnology ETF - IBB
The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.Latest shares articles

Buzzi stock forecast: H1 EBITDA and margin pressure
Buzzi is an Italian building-materials group listed in Milan, with recent trading shaped by a September share-price decline and a new investor presentation. Explore third-party BZU price targets and technical analysis. Past performance is not a reliable indicator of future results.
11:07, 25 September 2026

PKO BP stock forecast: POLSTR mortgages, KNF penalties
PKO Bank Polski introduced POLSTR 1M-linked mortgages from 3 September and is seeking reconsideration of five KNF penalties totalling 47.5m PLN. Explore third-party PKO price targets and technical analysis. Past performance is not a reliable indicator of future results.
11:40, 24 September 2026

Soitec stock forecast: €500m ORNANE bond
Soitec is a French semiconductor materials company. In September 2026, it placed €500m of 0.5% ORNANEs due in 2033, with settlement expected on 25 September. Explore third-party SOI price targets and technical analysis. Past performance is not a reliable indicator of future results.
10:51, 24 September 2026

Vossloh stock forecast: RTI acquisition expands digital rail
Vossloh is a German rail-infrastructure group that completed its acquisition of Rail Technology International on 15 September, expanding its digital inspection and analytics offering. Explore third-party VOS price targets. Past performance is not a reliable indicator of future results.
11:09, 23 September 2026
Related News
Public Technologies•Europe